72 related articles for article (PubMed ID: 8888801)
1. Angiogenesis in follicular tumors of the thyroid.
Segal K; Shpitzer T; Feinmesser M; Stern Y; Feinmesser R
J Surg Oncol; 1996 Oct; 63(2):95-8. PubMed ID: 8888801
[TBL] [Abstract][Full Text] [Related]
2. Computerized nuclear morphometry and quantitation of angiogenesis in thyroid neoplasms.
Kavantzas N; Tseleni-Balafouta S; Davaris P
J Exp Clin Cancer Res; 2002 Jun; 21(2):247-54. PubMed ID: 12148586
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic applicability of dipeptidyl aminopeptidase IV activity in cytological samples for differentiating follicular thyroid carcinoma from follicular adenoma.
Maruta J; Hashimoto H; Yamashita H; Yamashita H; Noguchi S
Arch Surg; 2004 Jan; 139(1):83-8. PubMed ID: 14718282
[TBL] [Abstract][Full Text] [Related]
4. Expression of vascular endothelial growth factor (VEGF) in human thyroid tumors.
Lewy-Trenda I; Wierzchniewska-Ławska A
Pol J Pathol; 2002; 53(3):129-32. PubMed ID: 12476614
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
[TBL] [Abstract][Full Text] [Related]
6. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma.
Umbricht CB; Saji M; Westra WH; Udelsman R; Zeiger MA; Sukumar S
Cancer Res; 1997 Jun; 57(11):2144-7. PubMed ID: 9187112
[TBL] [Abstract][Full Text] [Related]
9. Metalloproteinase-9 immunoexpression and angiogenesis in thyroid follicular neoplasms: relation to clinical and histopathologic features.
FrigugliettI CU; Mello ES; Castro IV; Filho GB; Alves VA
Head Neck; 2000 Jul; 22(4):373-9. PubMed ID: 10862021
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas.
Bryson PC; Shores CG; Hart C; Thorne L; Patel MR; Richey L; Farag A; Zanation AM
Arch Otolaryngol Head Neck Surg; 2008 Jun; 134(6):581-6. PubMed ID: 18559722
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of nm23 protein expression in thyroid papillary carcinoma and follicular neoplasm.
Tabriz HM; Adabi Kh; Lashkari A; Heshmat R; Haghpanah V; Larijani B; Tavangar SM
Pathol Res Pract; 2009; 205(2):83-7. PubMed ID: 18996649
[TBL] [Abstract][Full Text] [Related]
12. HBME-1 expression in follicular tumor of the thyroid: an investigation of whether it can be used as a marker to diagnose follicular carcinoma.
Ito Y; Yoshida H; Tomoda C; Miya A; Kobayashi K; Matsuzuka F; Kakudo K; Kuma K; Miyauchi A
Anticancer Res; 2005; 25(1A):179-82. PubMed ID: 15816536
[TBL] [Abstract][Full Text] [Related]
13. Analysis of P161NK4A protein expression in follicular thyroid tumors.
Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Sałacińska-Loś E; Kulig A; Włoch J
Pol J Pathol; 2004; 55(4):143-8. PubMed ID: 15757201
[TBL] [Abstract][Full Text] [Related]
14. Clinical relevance of vascular endothelial growth factor for thyroid neoplasms.
Huang SM; Lee JC; Wu TJ; Chow NH
World J Surg; 2001 Mar; 25(3):302-6. PubMed ID: 11343180
[TBL] [Abstract][Full Text] [Related]
15. Intravascular Kaposi's-like spindle cell proliferation of the capsular vessels of follicular-derived thyroid carcinomas.
Baloch ZW; LiVolsi VA
Mod Pathol; 1998 Oct; 11(10):995-8. PubMed ID: 9796729
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta type II receptors and smad proteins in follicular thyroid tumors.
West J; Munoz-Antonia T; Johnson JG; Klotch D; Muro-Cacho CA
Laryngoscope; 2000 Aug; 110(8):1323-7. PubMed ID: 10942134
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas.
Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY
Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932
[TBL] [Abstract][Full Text] [Related]
18. Angioarchitecture of thyroid carcinoma.
Watanabe I; Matsuura K
Jpn J Clin Oncol; 1985 Mar; 15(1):77-85. PubMed ID: 2580109
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasms.
Kebebew E; Peng M; Reiff E; Duh QY; Clark OH; McMillan A
Surgery; 2005 Dec; 138(6):1102-9; discussion 1109-10. PubMed ID: 16360397
[TBL] [Abstract][Full Text] [Related]
20. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
